HEADER    ANTIFUNGAL PROTEIN                      12-MAY-03   1P9G              
TITLE     CRYSTAL STRUCTURE OF A NOVEL ANTIFUNGAL PROTEIN DISTINCT WITH FIVE    
TITLE    2 DISULFIDE BRIDGES FROM ECOMMIA ULMOIDES OLIVER AT ATOMIC RESOLUTION  
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: EAFP 2;                                                    
COMPND   3 CHAIN: A                                                             
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: EUCOMMIA ULMOIDES;                              
SOURCE   3 ORGANISM_TAXID: 4392;                                                
SOURCE   4 TISSUE: TREE BARK                                                    
KEYWDS    ANTIFUNGAL PEPTIDE, ATOMIC RESOLUTION, ANTIFUNGAL PROTEIN             
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    Y.XIANG,R.H.HUANG,X.Z.LIU,D.C.WANG                                    
REVDAT   6   25-DEC-19 1P9G    1       SEQRES LINK                              
REVDAT   5   11-OCT-17 1P9G    1       REMARK                                   
REVDAT   4   24-FEB-09 1P9G    1       VERSN                                    
REVDAT   3   05-OCT-04 1P9G    1       JRNL                                     
REVDAT   2   15-JUN-04 1P9G    1       SOURCE                                   
REVDAT   1   01-JUN-04 1P9G    0                                                
JRNL        AUTH   Y.XIANG,R.H.HUANG,X.Z.LIU,Y.ZHANG,D.C.WANG                   
JRNL        TITL   CRYSTAL STRUCTURE OF A NOVEL ANTIFUNGAL PROTEIN DISTINCT     
JRNL        TITL 2 WITH FIVE DISULFIDE BRIDGES FROM EUCOMMIA ULMOIDES OLIVER AT 
JRNL        TITL 3 AN ATOMIC RESOLUTION.                                        
JRNL        REF    J.STRUCT.BIOL.                V. 148    86 2004              
JRNL        REFN                   ISSN 1047-8477                               
JRNL        PMID   15363789                                                     
JRNL        DOI    10.1016/J.JSB.2004.04.002                                    
REMARK   2                                                                      
REMARK   2 RESOLUTION.    0.84 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SHELXL-97                                            
REMARK   3   AUTHORS     : G.M.SHELDRICK                                        
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 0.84                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 100.00                         
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 86.8                           
REMARK   3   CROSS-VALIDATION METHOD           : FREE R                         
REMARK   3   FREE R VALUE TEST SET SELECTION   : RANDOM                         
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (NO CUTOFF).                         
REMARK   3   R VALUE   (WORKING + TEST SET, NO CUTOFF) : 0.068                  
REMARK   3   R VALUE          (WORKING SET, NO CUTOFF) : 0.068                  
REMARK   3   FREE R VALUE                  (NO CUTOFF) : 0.079                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.000                  
REMARK   3   FREE R VALUE TEST SET COUNT   (NO CUTOFF) : 885                    
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (NO CUTOFF) : 22113                  
REMARK   3                                                                      
REMARK   3  FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).                     
REMARK   3   R VALUE   (WORKING + TEST SET, F>4SIG(F)) : 0.065                  
REMARK   3   R VALUE          (WORKING SET, F>4SIG(F)) : 0.065                  
REMARK   3   FREE R VALUE                  (F>4SIG(F)) : 0.076                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 4.000                  
REMARK   3   FREE R VALUE TEST SET COUNT   (F>4SIG(F)) : 821                    
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (F>4SIG(F)) : 20593                  
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS      : 282                                           
REMARK   3   NUCLEIC ACID ATOMS : 0                                             
REMARK   3   HETEROGEN ATOMS    : 8                                             
REMARK   3   SOLVENT ATOMS      : 61                                            
REMARK   3                                                                      
REMARK   3  MODEL REFINEMENT.                                                   
REMARK   3   OCCUPANCY SUM OF NON-HYDROGEN ATOMS      : 345.50                  
REMARK   3   OCCUPANCY SUM OF HYDROGEN ATOMS          : 249.00                  
REMARK   3   NUMBER OF DISCRETELY DISORDERED RESIDUES : 7                       
REMARK   3   NUMBER OF LEAST-SQUARES PARAMETERS       : 3401                    
REMARK   3   NUMBER OF RESTRAINTS                     : 3876                    
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.                        
REMARK   3   BOND LENGTHS                         (A) : 0.017                   
REMARK   3   ANGLE DISTANCES                      (A) : 0.035                   
REMARK   3   SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000                   
REMARK   3   DISTANCES FROM RESTRAINT PLANES      (A) : 0.033                   
REMARK   3   ZERO CHIRAL VOLUMES               (A**3) : 0.150                   
REMARK   3   NON-ZERO CHIRAL VOLUMES           (A**3) : 0.142                   
REMARK   3   ANTI-BUMPING DISTANCE RESTRAINTS     (A) : 0.000                   
REMARK   3   RIGID-BOND ADP COMPONENTS         (A**2) : 0.008                   
REMARK   3   SIMILAR ADP COMPONENTS            (A**2) : 0.032                   
REMARK   3   APPROXIMATELY ISOTROPIC ADPS      (A**2) : 0.000                   
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228        
REMARK   3                                                                      
REMARK   3  STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER                        
REMARK   3   SPECIAL CASE: CSD L-PYROGLUTAMIC ACID DATA FOR PCA                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: ANISOTROPIC REFINEMENT REDUCED FREE R     
REMARK   3  (NO CUTOFF) BY 5%                                                   
REMARK   4                                                                      
REMARK   4 1P9G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-MAY-03.                  
REMARK 100 THE DEPOSITION ID IS D_1000019174.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 12-MAR-02                          
REMARK 200  TEMPERATURE           (KELVIN) : 283                                
REMARK 200  PH                             : 5.5                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : PHOTON FACTORY                     
REMARK 200  BEAMLINE                       : BL-18B                             
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.0                                
REMARK 200  MONOCHROMATOR                  : SILICON (111)                      
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 4                     
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 22113                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 0.840                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 100.000                            
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 0.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 86.8                               
REMARK 200  DATA REDUNDANCY                : 3.400                              
REMARK 200  R MERGE                    (I) : 0.05100                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 26.6000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.84                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 0.87                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 70.4                               
REMARK 200  DATA REDUNDANCY IN SHELL       : NULL                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.14000                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 8.500                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO PHASING            
REMARK 200 SOFTWARE USED: SNB                                                   
REMARK 200 STARTING MODEL: NULL                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 23.31                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.39                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM ACETATE, ISO-PROPANOL, PH 5.5,    
REMARK 280  VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K                     
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1                         
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,Y+1/2,-Z                                             
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000       11.58900            
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    ARG A   9   N   -  CA  -  CB  ANGL. DEV. =  11.7 DEGREES          
REMARK 500    ARG A   9   NE  -  CZ  -  NH2 ANGL. DEV. =   3.0 DEGREES          
REMARK 500    TYR A  20   CB  -  CG  -  CD1 ANGL. DEV. =  -5.0 DEGREES          
REMARK 500    SER A  25   N   -  CA  -  CB  ANGL. DEV. =  -9.7 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 42                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 43                  
REMARK 999                                                                      
REMARK 999 IT APPEARS THAT THIS PROTEIN SEQUENCE HAS NOT BEEN DEPOSITED IN      
REMARK 999 THE SEQUENCE DATABASE.                                               
DBREF  1P9G A    1    41  UNP    P83597   EAP2_EUCUL       1     41             
SEQRES   1 A   41  PCA THR CYS ALA SER ARG CYS PRO ARG PRO CYS ASN ALA          
SEQRES   2 A   41  GLY LEU CYS CYS SER ILE TYR GLY TYR CYS GLY SER GLY          
SEQRES   3 A   41  ALA ALA TYR CYS GLY ALA GLY ASN CYS ARG CYS GLN CYS          
SEQRES   4 A   41  ARG GLY                                                      
MODRES 1P9G PCA A    1  GLN  PYROGLUTAMIC ACID                                  
HET    PCA  A   1      14                                                       
HET    ACT  A  42       4                                                       
HET    ACT  A  43       4                                                       
HETNAM     PCA PYROGLUTAMIC ACID                                                
HETNAM     ACT ACETATE ION                                                      
FORMUL   1  PCA    C5 H7 N O3                                                   
FORMUL   2  ACT    2(C2 H3 O2 1-)                                               
FORMUL   4  HOH   *61(H2 O)                                                     
HELIX    1   1 THR A    2  CYS A    7  5                                   6    
HELIX    2   2 GLY A   26  GLY A   31  1                                   6    
SHEET    1   A 3 CYS A  23  GLY A  24  0                                        
SHEET    2   A 3 CYS A  16  SER A  18 -1  N  CYS A  16   O  GLY A  24           
SHEET    3   A 3 CYS A  35  CYS A  37 -1  O  ARG A  36   N  CYS A  17           
SSBOND   1 CYS A    3    CYS A   17                          1555   1555  2.03  
SSBOND   2 CYS A    7    CYS A   37                          1555   1555  2.03  
SSBOND   3 CYS A   11    CYS A   23                          1555   1555  2.03  
SSBOND   4 CYS A   16    CYS A   30                          1555   1555  2.03  
SSBOND   5 CYS A   35    CYS A   39                          1555   1555  2.02  
LINK         C   PCA A   1                 N   THR A   2     1555   1555  1.30  
CISPEP   1 CYS A    7    PRO A    8          0        17.57                     
SITE     1 AC1  8 PCA A   1  CYS A   3  ARG A   6  GLY A  21                    
SITE     2 AC1  8 TYR A  22  CYS A  23  HOH A  58  HOH A  71                    
SITE     1 AC2  5 ASN A  12  ALA A  13  ARG A  40  HOH A  53                    
SITE     2 AC2  5 HOH A  73                                                     
CRYST1   19.011   23.178   30.720  90.00  98.56  90.00 P 1 21 1      2          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.052601  0.000000  0.007918        0.00000                         
SCALE2      0.000000  0.043144  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.032919        0.00000                         
ATOM     16  CA  THR A   2       0.708  -5.416 -12.414  1.00  6.25           C  
ANISOU   16  CA  THR A   2      613    897    864    -73    202   -471       C  
ATOM     30  CA  CYS A   3      -1.913  -4.859  -9.726  1.00  3.64           C  
ANISOU   30  CA  CYS A   3      521    428    434      3     13    -79       C  
ATOM     40  CA  ALA A   4      -4.912  -5.361 -12.023  1.00  4.07           C  
ANISOU   40  CA  ALA A   4      573    437    537    -95    -13    -11       C  
ATOM     50  CA  SER A   5      -3.981  -9.027 -12.430  1.00  5.13           C  
ANISOU   50  CA  SER A   5      988    448    513   -130     94   -202       C  
ATOM     66  CA  ARG A   6      -4.829  -9.512  -8.745  1.00  4.14           C  
ANISOU   66  CA  ARG A   6      651    382    541    -32     35     36       C  
ATOM     90  CA  CYS A   7      -8.182  -7.731  -8.738  1.00  4.00           C  
ANISOU   90  CA  CYS A   7      663    460    396    -79     25   -108       C  
ATOM    100  CA  PRO A   8     -10.419  -7.843  -6.789  1.00  5.59           C  
ANISOU  100  CA  PRO A   8      697    809    618     62    132      2       C  
ATOM    114  CA  ARG A   9      -7.877  -7.331  -3.989  1.00  4.56           C  
ANISOU  114  CA  ARG A   9      963    361    406     -3    168      6       C  
ATOM    156  CA  PRO A  10      -4.320  -6.595  -5.130  1.00  4.50           C  
ANISOU  156  CA  PRO A  10      780    568    360     27    -26    -77       C  
ATOM    179  CA  CYS A  11      -3.171  -4.290  -2.362  1.00  3.57           C  
ANISOU  179  CA  CYS A  11      542    461    355     39    -62    -10       C  
ATOM    189  CA  ASN A  12      -2.762  -3.863   1.373  1.00  3.47           C  
ANISOU  189  CA  ASN A  12      449    519    351     37    -76     29       C  
ATOM    203  CA  ALA A  13      -5.892  -2.582   3.094  1.00  5.54           C  
ANISOU  203  CA  ALA A  13      522   1101    482    241     98    299       C  
ATOM    213  CA  GLY A  14      -6.530   1.089   2.627  1.00  5.36           C  
ANISOU  213  CA  GLY A  14      715    878    443    175    141    -66       C  
ATOM    220  CA  LEU A  15      -4.755   1.155  -0.716  1.00  2.98           C  
ANISOU  220  CA  LEU A  15      463    416    253    -26    -43    -27       C  
ATOM    239  CA  CYS A  16      -6.254   0.996  -4.199  1.00  2.44           C  
ANISOU  239  CA  CYS A  16      351    363    213    -55    -32    -28       C  
ATOM    249  CA  CYS A  17      -4.973  -0.456  -7.484  1.00  2.56           C  
ANISOU  249  CA  CYS A  17      339    384    248     19    -15      3       C  
ATOM    259  CA  SER A  18      -4.475   2.265 -10.087  1.00  3.37           C  
ANISOU  259  CA  SER A  18      517    442    322    -13    -21     81       C  
ATOM    270  CA  ILE A  19      -5.013   2.074 -13.849  1.00  3.85           C  
ANISOU  270  CA  ILE A  19      532    580    349    -46     -8     80       C  
ATOM    289  CA  TYR A  20      -1.222   2.219 -14.219  1.00  5.26           C  
ANISOU  289  CA  TYR A  20      601    916    483     31    170    176       C  
ATOM    310  CA  GLY A  21      -0.706  -0.944 -12.188  1.00  4.50           C  
ANISOU  310  CA  GLY A  21      609    743    357     73    -47   -118       C  
ATOM    317  CA  TYR A  22       0.432   0.296  -8.776  1.00  3.49           C  
ANISOU  317  CA  TYR A  22      459    557    311    -29     -9    -71       C  
ATOM    338  CA  CYS A  23      -1.073   0.256  -5.306  1.00  3.17           C  
ANISOU  338  CA  CYS A  23      411    435    357     46     36    -78       C  
ATOM    348  CA  GLY A  24      -1.349   3.494  -3.341  1.00  3.36           C  
ANISOU  348  CA  GLY A  24      412    415    449    -15     -9    -81       C  
ATOM    355  CA  SER A  25      -3.486   5.670  -1.121  1.00  3.83           C  
ANISOU  355  CA  SER A  25      580    418    456     11     37    -85       C  
ATOM    371  CA  GLY A  26      -5.811   8.612  -1.355  1.00  4.41           C  
ANISOU  371  CA  GLY A  26      566    571    538    124     -4   -148       C  
ATOM    378  CA  ALA A  27      -7.815  10.075  -4.166  1.00  5.66           C  
ANISOU  378  CA  ALA A  27      799    678    674    224   -215   -167       C  
ATOM    388  CA  ALA A  28      -4.643   9.937  -6.254  1.00  5.69           C  
ANISOU  388  CA  ALA A  28      922    585    657   -205    -88    125       C  
ATOM    398  CA  TYR A  29      -5.044   6.131  -6.531  1.00  3.91           C  
ANISOU  398  CA  TYR A  29      488    655    341      0      3    -12       C  
ATOM    419  CA  CYS A  30      -8.653   5.553  -5.484  1.00  3.51           C  
ANISOU  419  CA  CYS A  30      487    462    386      6     13    -85       C  
ATOM    429  CA  GLY A  31     -10.527   8.267  -7.398  1.00  5.60           C  
ANISOU  429  CA  GLY A  31      904    732    492    315     -7     38       C  
ATOM    437  CA AALA A  32     -12.589   7.332 -10.412  0.50  7.56           C  
ANISOU  437  CA AALA A  32      944   1090    837   -223   -248    129       C  
ATOM    438  CA BALA A  32     -12.567   7.871 -10.516  0.50  8.05           C  
ANISOU  438  CA BALA A  32      707   1504    847     49   -275    143       C  
ATOM    457  CA AGLY A  33     -10.165   8.443 -13.059  0.50  7.10           C  
ANISOU  457  CA AGLY A  33     1264    887    545     10   -263    300       C  
ATOM    458  CA BGLY A  33     -10.149   8.019 -13.454  0.50  8.44           C  
ANISOU  458  CA BGLY A  33     1238   1432    535    343   -185    146       C  
ATOM    470  CA  ASN A  34      -7.227   6.715 -11.423  1.00  4.42           C  
ANISOU  470  CA  ASN A  34      677    491    510   -110     28    113       C  
ATOM    484  CA  CYS A  35      -8.679   3.553  -9.872  1.00  3.31           C  
ANISOU  484  CA  CYS A  35      501    378    378    -25    -49     45       C  
ATOM    494  CA  ARG A  36      -8.862   0.120 -11.489  1.00  3.27           C  
ANISOU  494  CA  ARG A  36      597    381    262    -28    -68     14       C  
ATOM    518  CA  CYS A  37     -10.073  -1.928  -8.514  1.00  3.14           C  
ANISOU  518  CA  CYS A  37      384    488    321    -35    -40     13       C  
ATOM    528  CA  GLN A  38      -9.970  -2.101  -4.715  1.00  2.95           C  
ANISOU  528  CA  GLN A  38      432    371    317    -47     36     30       C  
ATOM    545  CA  CYS A  39     -11.315   1.444  -4.868  1.00  3.64           C  
ANISOU  545  CA  CYS A  39      428    488    468     70    -14    153       C  
ATOM    555  CA  ARG A  40     -12.617   1.372  -1.290  1.00  3.22           C  
ANISOU  555  CA  ARG A  40      464    323    438     24      8     34       C  
ATOM    579  CA  GLY A  41      -9.367   0.053   0.175  1.00  3.78           C  
ANISOU  579  CA  GLY A  41      441    372    624     29    -85     40       C  
TER     580      GLY A  41                                                      
END                                                                             
